Cavium, Inc. (NASDAQ:CAVM) has received an average rating of “Buy” from the twenty-one brokerages that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and thirteen have given a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $73.36.

CAVM has been the topic of several recent analyst reports. Argus raised their price objective on Cavium from $75.00 to $82.00 and gave the company a “buy” rating in a research note on Tuesday, March 14th. Barclays PLC raised their price objective on Cavium from $70.00 to $80.00 and gave the company an “overweight” rating in a research note on Monday, March 6th. Macquarie initiated coverage on Cavium in a research note on Thursday, March 30th. They set an “outperform” rating and a $85.00 price objective on the stock. BidaskClub cut Cavium from a “buy” rating to a “hold” rating in a research note on Wednesday, June 14th. Finally, Morgan Stanley raised their price objective on Cavium from $75.00 to $80.00 and gave the company an “overweight” rating in a research note on Friday, April 28th.

In other Cavium news, SVP Vincent P. Pangrazio sold 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $75.73, for a total value of $1,135,950.00. Following the completion of the sale, the senior vice president now owns 60,039 shares in the company, valued at $4,546,753.47. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Arthur D. Chadwick sold 40,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The shares were sold at an average price of $75.14, for a total value of $3,005,600.00. Following the completion of the sale, the vice president now owns 75,383 shares of the company’s stock, valued at approximately $5,664,278.62. The disclosure for this sale can be found here. Insiders own 4.65% of the company’s stock.

A number of hedge funds have recently made changes to their positions in CAVM. FMR LLC increased its stake in shares of Cavium by 1.2% in the first quarter. FMR LLC now owns 10,174,578 shares of the semiconductor provider’s stock valued at $729,110,000 after buying an additional 124,068 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Cavium by 4.3% in the first quarter. Vanguard Group Inc. now owns 5,121,457 shares of the semiconductor provider’s stock valued at $367,004,000 after buying an additional 211,144 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of Cavium by 8.1% in the first quarter. Wellington Management Group LLP now owns 4,491,559 shares of the semiconductor provider’s stock valued at $321,865,000 after buying an additional 336,243 shares during the last quarter. BlackRock Inc. increased its stake in shares of Cavium by 64,275.6% in the first quarter. BlackRock Inc. now owns 4,382,691 shares of the semiconductor provider’s stock valued at $314,065,000 after buying an additional 4,375,883 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Cavium by 29.5% in the first quarter. JPMorgan Chase & Co. now owns 2,964,350 shares of the semiconductor provider’s stock valued at $212,424,000 after buying an additional 675,059 shares during the last quarter.

Shares of Cavium (CAVM) traded down 2.25% during mid-day trading on Tuesday, hitting $60.73. 562,499 shares of the stock were exchanged. The stock’s market capitalization is $4.12 billion. Cavium has a 12-month low of $35.97 and a 12-month high of $76.26. The stock’s 50 day moving average price is $70.04 and its 200-day moving average price is $67.94.

Cavium (NASDAQ:CAVM) last issued its quarterly earnings data on Wednesday, April 26th. The semiconductor provider reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.29 by $0.09. Cavium had a negative net margin of 26.52% and a positive return on equity of 4.05%. The company had revenue of $229.58 million for the quarter, compared to the consensus estimate of $227.22 million. During the same quarter last year, the business posted $0.25 earnings per share. Cavium’s revenue was up 125.3% on a year-over-year basis. On average, equities research analysts expect that Cavium will post $2.78 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This article was published by American Banking News and is the property of of American Banking News. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at https://www.americanbankingnews.com/2017/07/04/cavium-inc-cavm-receives-consensus-recommendation-of-buy-from-analysts.html.

About Cavium

Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.

Analyst Recommendations for Cavium (NASDAQ:CAVM)

Receive News & Ratings for Cavium Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium Inc. and related companies with MarketBeat.com's FREE daily email newsletter.